Anzeige
Mehr »
Login
Donnerstag, 21.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Triangle IPO eröffnet mögliche 900 Mio. CAD Bewertung für Halo Collective
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVYK ISIN: US81663L1017 Ticker-Symbol:  
NASDAQ
21.10.21
16:59 Uhr
7,650 US-Dollar
-0,050
-0,65 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEMA4 HOLDINGS CORP Chart 1 Jahr
5-Tage-Chart
SEMA4 HOLDINGS CORP 5-Tage-Chart

Aktuelle News zur SEMA4 Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SEMA4 Aktie jetzt für 0€ handeln
DiSema4 Holdings Corp.: Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021-
14.10.Sema4 Holdings Corp. - 8-K, Current Report1
27.09.Sema4 Holdings Corp. - S-8, Securities to be offered to employees in employee benefit plans1
24.09.Sema4 trades high on Buy initiation at Jefferies on attractive valuation2
30.08.Sema4 Holdings Corp.: Sema4 to Participate at Two Upcoming Investor Conferences in September2
17.08.Why Sema4 Holdings Stock Is Sinking Today9
17.08.Sema4 shares slide 16% on wider Q2 net loss, revenue target update2
17.08.Virpax Pharmaceuticals, Sesen Bio leads healthcare gainers; Qualigen Therapeutics, Sema4 among major losers29
16.08.Mount Sinai Genomics, Inc. d/b/a Sema4: Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights1
04.08.Sema4 Holdings Corp. - S-1, General form for registration of securities1
02.08.Mount Sinai Genomics, Inc. d/b/a Sema4: Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021-
28.07.Sema4 Holdings Corp. - 8-K, Current Report2
28.07.Mount Sinai Genomics, Inc. d/b/a Sema4: Sema4 to Participate at Two Upcoming Investor Conferences in August1
26.07.Mount Sinai Health System-backed Sema4 goes public at $3B valuation1
23.07.Sema4 Holdings (SMFR) Stock Is a Good Buy After the CMLF Merger3
22.07.Sema4 goes public via SPAC merger1
22.07.Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company220Sema4 Holdings Corp ("Sema4") to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal...
► Artikel lesen
17.06.Ahead of SPAC deal sign-off, Sema4 recruits its first data chief from Mount Sinai2
07.06.Bionano Genomics Appoints Jason Priar, Former GeneDx, Sema4 and PerkinElmer Genomics Sales Leader, as its Chief Commercial Officer32
28.05.AdventHealth, Sema4 partner to launch precision medicine program1
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1